Search research articles
Contact Us
Filters
Showing results (271-280 of 350) with videos related to
Page
of 35
Sort By:
Journal of Crohn'S & Colitis
|
November 1, 2024
Risankizumab Is Associated With Normalization of Biomarkers in Patients With Crohn's Disease: Results From the Phase 3 ADVANCE, MOTIVATE, and FORTIFY Studies
Raja Atreya, Marc Ferrante, Remo Panaccione, et al.
Gastroenterology
|
September 6, 2011
Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium
Toshiro Sato, Daniel E Stange, Marc Ferrante, et al.
Journal of Crohn'S & Colitis
|
January 19, 2019
Gene and Mirna Regulatory Networks During Different Stages of Crohn's Disease
Sare Verstockt, Gert De Hertogh, Jan Van der Goten, et al.
Inflammatory Bowel Diseases
|
May 3, 2008
Transcriptomic analysis of intestinal fibrosis-associated gene expression in response to medical therapy in Crohn's disease
John P Burke, Marc Ferrante, Karen Dejaegher, et al.
Gastroenterology
|
February 26, 2026
The effect of dose-intensification after secondary loss of response to ustekinumab in Crohn's disease: Results of the REScUE study
Peter Bossuyt, Jean-Francois Rahier, Filip Baert, et al.
Journal of Crohn'S & Colitis
|
March 24, 2026
Personalized infliximab rescue therapy to maximize colectomy-free survival in patients with acute severe ulcerative colitis
Emmanuel Niyigena, Yannick Hoffert, Waqqas Afif, et al.
Plos One
|
July 30, 2013
Unique gene expression and MR T2 relaxometry patterns define chronic murine dextran sodium sulphate colitis as a model for connective tissue changes in human Crohn's disease
Christine Breynaert, Tom Dresselaers, Clémentine Perrier, et al.
United European Gastroenterology Journal
|
May 19, 2018
Efficacy of vedolizumab for induction of clinical response and remission in patients with moderate to severe inflammatory bowel disease who failed at least two TNF antagonists
Martine De Vos, Barbara Dhooghe, Severine Vermeire, et al.
Journal of Crohn'S & Colitis
|
January 21, 2012
Physician perspectives on unresolved issues in the use of conventional therapy in Crohn's disease: results from an international survey and discussion programme
Marc Ferrante, Konstantinos Karmiris, Evan Newnham, et al.
Journal of Clinical Medicine
|
April 26, 2025
The Development of a Multidisciplinary Care Pathway for Patients with Inflammatory Bowel Disease Before, During and After Pregnancy
Els De Dycker, Sien Lenie, Michael Ceulemans, et al.
Page
of 35
Search research articles
Search
Showing results (271-280 of 350) with videos related to
Sort By:
Page
of 35
Journal of Crohn'S & Colitis
|
November 1, 2024
Risankizumab Is Associated With Normalization of Biomarkers in Patients With Crohn's Disease: Results From the Phase 3 ADVANCE, MOTIVATE, and FORTIFY Studies
Raja Atreya, Marc Ferrante, Remo Panaccione, et al.
Gastroenterology
|
September 6, 2011
Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium
Toshiro Sato, Daniel E Stange, Marc Ferrante, et al.
Journal of Crohn'S & Colitis
|
January 19, 2019
Gene and Mirna Regulatory Networks During Different Stages of Crohn's Disease
Sare Verstockt, Gert De Hertogh, Jan Van der Goten, et al.
Inflammatory Bowel Diseases
|
May 3, 2008
Transcriptomic analysis of intestinal fibrosis-associated gene expression in response to medical therapy in Crohn's disease
John P Burke, Marc Ferrante, Karen Dejaegher, et al.
Gastroenterology
|
February 26, 2026
The effect of dose-intensification after secondary loss of response to ustekinumab in Crohn's disease: Results of the REScUE study
Peter Bossuyt, Jean-Francois Rahier, Filip Baert, et al.
Journal of Crohn'S & Colitis
|
March 24, 2026
Personalized infliximab rescue therapy to maximize colectomy-free survival in patients with acute severe ulcerative colitis
Emmanuel Niyigena, Yannick Hoffert, Waqqas Afif, et al.
Plos One
|
July 30, 2013
Unique gene expression and MR T2 relaxometry patterns define chronic murine dextran sodium sulphate colitis as a model for connective tissue changes in human Crohn's disease
Christine Breynaert, Tom Dresselaers, Clémentine Perrier, et al.
United European Gastroenterology Journal
|
May 19, 2018
Efficacy of vedolizumab for induction of clinical response and remission in patients with moderate to severe inflammatory bowel disease who failed at least two TNF antagonists
Martine De Vos, Barbara Dhooghe, Severine Vermeire, et al.
Journal of Crohn'S & Colitis
|
January 21, 2012
Physician perspectives on unresolved issues in the use of conventional therapy in Crohn's disease: results from an international survey and discussion programme
Marc Ferrante, Konstantinos Karmiris, Evan Newnham, et al.
Journal of Clinical Medicine
|
April 26, 2025
The Development of a Multidisciplinary Care Pathway for Patients with Inflammatory Bowel Disease Before, During and After Pregnancy
Els De Dycker, Sien Lenie, Michael Ceulemans, et al.
Page
of 35